Tech Company Financing Transactions

Gossamer Bio Funding Round

Arch Venture Partners, Omega Funds and private investors participated in a $100 million Series A funding round for Gossamer Bio. The round was announced by the company on 1/6/2018.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

846 Hal St.
San Diego, CA 92102
USA

Phone

(619) 262-8759

Website

www.gossamerbio.com

Email Address

[email protected]

Overview

Gossamer Bio (Nasdaq: GOSS) is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Faheem Hasnain

        

Chief Financial Officer

Bryan Giraudo

        

Chief Operating Officer

Sheila Gujrathi

        

VP - General Counsel

Christian Waage

        

VP - Human Resources

Deanna Weber

        

Browse more venture capital transactions:

Prev: 1/6/2018: Genome Medical venture capital transaction
Next: 1/6/2018: Immusoft venture capital transaction

Share this article

Where The Data Comes From

We do our best to document all VC transactions involving tech companies. VC transactions on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary